Ryman Healthcare enjoyed its best week in almost two years.
Mass spectrometer company’s new pharmaceutical-focused product has been released this month.
The $50m capital raising was underwritten by Goldman Sachs and Cannacord Genuity.
NZRegCo says three situations have occurred in last five years where it would have contemplated its new alert tool.
UK coffee brand Triple Two will enter administration in the next few weeks as Covid lag bites.
More international competition, volatile fuel prices, a weaker New Zealand dollar, ongoing wage inflation, and increased airport charges all weigh.
Analysts question milk processor on what happens if it can’t sell its Dairyworks unit by March 31 bank deadline.
Result for year to July comes in near bottom of guidance as company works to reduce debt.
All directors subscribed for more shares in the company's recent $11.6m institutional placement.
‘Imagine the damage we could do if we can get some people coming back more regularly,’ KMD Brands managing director says.
